7Baggers
 10 best small-cap biotech stocks to buy according to analysts  Insider Monkey Sat, 15 Nov 2025 12:36:01 GMT
 Why Structure Therapeutics Shares Are On The Rise  TipRanks Fri, 14 Nov 2025 15:25:41 GMT
 Structure Therapeutics Reports Q3 2025 Financial Results  TipRanks Tue, 11 Nov 2025 04:19:59 GMT
 Structure Therapeutics stock holds Outperform rating at BMO ahead of key data  Investing.com Nigeria Mon, 10 Nov 2025 18:51:11 GMT
 Decoding Structure Therapeutics Inc (GPCR): A Strategic SWOT Ins  GuruFocus Sat, 08 Nov 2025 05:25:08 GMT
 Interesting GPCR Put And Call Options For December 2026  Nasdaq Fri, 07 Nov 2025 16:03:00 GMT
 structure therapeutics : corporate presentation (november 2025)  MarketScreener Thu, 06 Nov 2025 23:47:17 GMT
 Structure Therapeutics Q3 loss widens to $65.7 mln  MarketScreener Thu, 06 Nov 2025 21:50:50 GMT
 structure therapeutics (nasdaq:gpcr) shares up 9.2% - still a buy?  MarketBeat Fri, 31 Oct 2025 23:09:04 GMT
 NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?  Zacks Investment Research Fri, 24 Oct 2025 07:00:00 GMT
 trading systems reacting to (gpcr) volatility  news.stocktradersdaily.com Sat, 18 Oct 2025 13:12:02 GMT
 structure therapeutics inc. (gpcr): investor outlook with a 142% potential upside  DirectorsTalk Interviews Tue, 14 Oct 2025 09:33:17 GMT
 structure therapeutics (nasdaq:gpcr) shares up 6.3% - what's next?  MarketBeat Sat, 20 Sep 2025 10:29:31 GMT
 top 10 ai-powered biotech stocks to buy now  Insider Monkey Thu, 18 Sep 2025 07:00:00 GMT
 structure therapeutics (nasdaq:gpcr) upgraded at lifesci capital  MarketBeat Mon, 15 Sep 2025 07:00:00 GMT
 brokers issue forecasts for gpcr q3 earnings  MarketBeat Sat, 13 Sep 2025 12:01:16 GMT
 structure therapeutics (nasdaq:gpcr) upgraded at lifesci capital  MarketBeat Fri, 12 Sep 2025 13:01:34 GMT
 this under-the-radar healthcare stock could soar in 2026  The Globe and Mail Fri, 12 Sep 2025 07:00:00 GMT
 is summit therapeutics a buy, sell, or hold now?  AOL.com Tue, 09 Sep 2025 10:19:17 GMT
 structure therapeutics inc. (gpcr) investor outlook: unpacking a 250% potential upside  DirectorsTalk Interviews Tue, 09 Sep 2025 07:00:00 GMT
 layoff tracker: ac immune to cut 30% of workforce  BioSpace Fri, 05 Sep 2025 07:00:00 GMT
 j.p. morgan maintains structure therapeutics(gpcr.us) with buy rating  富途牛牛 Thu, 04 Sep 2025 07:00:00 GMT
 structure therapeutics inc. (gpcr) stock analysis: exploring a 278.64% potential upside  DirectorsTalk Interviews Tue, 02 Sep 2025 07:00:00 GMT
 windtree therapeutics approves key financial structure changes  TipRanks Tue, 02 Sep 2025 07:00:00 GMT
 markets - medicine hat news  FinancialContent Tue, 02 Sep 2025 07:00:00 GMT

Structure Therapeutics Inc.
(NASDAQ:GPCR) 

GPCR stock logo

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 r...

Founded: 2016
IPO Price: $15 (Feb 03, 2023)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends